<SEC-DOCUMENT>0001437749-19-021270-index.html : 20191101
<SEC-HEADER>0001437749-19-021270.hdr.sgml : 20191101
<ACCEPTANCE-DATETIME>20191101144301
ACCESSION NUMBER:		0001437749-19-021270
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20191025
FILED AS OF DATE:		20191101
DATE AS OF CHANGE:		20191101

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Davis Todd C
		CENTRAL INDEX KEY:			0001392029

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35285
		FILM NUMBER:		191186531

	MAIL ADDRESS:	
		STREET 1:		11119 NORTH TORREY PINES ROAD
		STREET 2:		SUITE 200
		CITY:			LA JOLLA
		STATE:			CA
		ZIP:			92037

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Vaxart, Inc.
		CENTRAL INDEX KEY:			0000072444
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				591212264
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		290 UTAH AVE., SUITE 200
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		(650) 550-3500

	MAIL ADDRESS:	
		STREET 1:		290 UTAH AVE., SUITE 200
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Aviragen Therapeutics, Inc.
		DATE OF NAME CHANGE:	20160413

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Biota Pharmaceuticals, Inc.
		DATE OF NAME CHANGE:	20121113

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NABI BIOPHARMACEUTICALS
		DATE OF NAME CHANGE:	20100719
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>rdgdoc.xml
<DESCRIPTION>FORM 3
<TEXT>
Document 1 - file: rdgdoc.html

Document 1 - RAW XML: rdgdoc.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24
<SEQUENCE>2
<FILENAME>davispoa.htm
<TEXT>
Document 2 - file: davispoa.htm

</DOCUMENT>
</SEC-DOCUMENT>